{{cart_num}}
My CartCAS：81403-68-1
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：HPLC≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 81403-68-1 |
| Name | Alfuzosin Hydrochloride |
| Molecular Formula | C19H27N5O4·HCl |
| Molecular Weight | 425.91 |
| Solubility | Soluble in Water/DMSO ≥5mg/mL |
| Purity | HPLC≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 620-512-3 |
| MDL | MFCD00879135 |
| SMILES | O=C(C1OCCC1)NCCCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)C.Cl |
| Target Point | Adrenergic Receptor |
| Passage | Endocrinology & Hormones;GPCR & G Protein;Neuronal Signaling |
| Background | Alfuzosin hydrochloride/SL 77499-10 is an alpha 1 adrenergic receptor antagonist |
| Biological Activity | Alfuzosin, a new quinazoline derivative, acts as a selective and competitive antagonist of alpha 1-adrenoceptor-mediated contraction of prostatic, prostatic capsule, bladder base and proximal urethral smooth muscle, thereby reducing the tone of these structures. [1]Alfuzosin is a potent selective alpha1-adrenoceptor antagonist in tissues of the lower urinary tract including the human prostate. This provides a pharmacological basis for its use in the treatment of benign prostatic hypertrophy.[2] |
| In Vitro | Phenylephrine-induced contractions of rabbit isolated trigone and urethra were antagonized in a competitive manner by alfuzosin(pA2 7.44 and 7.30，respectively)and prazosin. [2] |
| In Vivo | In the pithed rat，alfuzosin(0.03-0.3 mg kg-1，i.v.)markedly inhibited pressor responses produced by the alpha 1-selective agonist，cirazoline but inhibited only slightly responses to the alpha 2-selective agonist，UK 14，304. Alfuzosin(1 mg kg-1，i.v.)had minimal effects against responses mediated by stimulation of prejunctional alpha 2-receptors(UK 14，304-induced inhibition of sympathetic tachycardia).[2] In the anaesthetized cat，alfuzosin(0.001-1 mg kg-1，i.v.)and prazosin(0.001-0.3 mg kg-1，i.v.)produced dose-related inhibition of the increases in urethral pressure caused by stimulation of sympathetic hypogastric nerves. [2] |
| Data Literature Source | [1]. Wilde MI，et al. Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties，and therapeutic potential in benign prostatic hyperplasia. Drugs. 1993 Mar;45(3):410-29. [2]. Lefèvre-Borg F，O'Connor SE，Schoemaker H，Hicks PE，Lechaire J，Gautier E，Pierre F，Pimoule C，Manoury P，Langer SZ. Alfuzosin，a selective alpha 1-adrenoceptor antagonist in the lower urinary tract. Br J Pharmacol. 1993 Aug;109(4):1282-9. |
| Unit | Bottle |
| Specification | 10mg 50mg 100mg |
是α1肾上腺素受体拮抗剂
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Immunohistochemistry of paraffin-embedded human colorectal cancer with ACOX2 antibody diluted at 1:100.
Manual Download
